生技仿製藥規範與公費報銷政策對藥廠經營策略之影響—美國, 歐洲與日本制度之比較分析
J Yamaguchi - 2014 - tdr.lib.ntu.edu.tw
… biosimilars, as well as a literature review of major works cited in this paper. In this section, the
concept … This analysis compares differences in the factors influencing corporate strategies …
concept … This analysis compares differences in the factors influencing corporate strategies …
[PDF][PDF] 基于显性AA 学说的安慰剂的医疗效果机制乌赫托姆斯基
AV Nikolaevich, PN Yakovlevich - 上合组织国家的科学研究: 协同和一体 … - scholar.archive.org
… Analysis of the placebo effect of a drug from the point of view … scientific fundamental basis
for the theory of placebo use. Works … The changing landscape of biosimilars in rheumatology/T. …
for the theory of placebo use. Works … The changing landscape of biosimilars in rheumatology/T. …
原发性肝癌的综合治疗研究进展
邢家利， 金保， 桑新亭， 毛一雷， 杜顺达 - 肿瘤综合治疗电子杂志, 2023 - jmcm2018.com
… Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: a
systematic review and Meta-analysis[J]. Hepatology, 2018, 67(1):381-400. [13] MAZZAFERRO V, …
systematic review and Meta-analysis[J]. Hepatology, 2018, 67(1):381-400. [13] MAZZAFERRO V, …
弥漫性大B 细胞淋巴瘤预后因素研究进展
汪太松， 乔文礼， 邢岩， 赵晋华 - 国际放射医学核医学杂志, 2020 - ijrmnm.com
… lymphoma and is characterized by strong heterogeneity… review discusses the prognostic
factors affecting DLBCL patients on the basis of clinical factors, molecular biology characteristics…
factors affecting DLBCL patients on the basis of clinical factors, molecular biology characteristics…
[HTML][HTML] 对于早期不可切除结直肠癌肝转移治疗的研究进展
王承相， 王成 - Advances in Clinical Medicine, 2023 - hanspub.org
… In this review, the author now presents an overview of the current status and research
progress in the treatment of liver metastases from early unresectable colorectal cancer. …
progress in the treatment of liver metastases from early unresectable colorectal cancer. …
[PDF][PDF] 角色之著作權保護—從內容產業的經驗思考電玩產業的現況
蔡鎛宇 - 更正啟事, 2017 - tiipm.nccu.edu.tw
… 由於電玩遊戲角色之分析亦是根源於概念與表達的 區分原則(the idea-expression dichotomy),
故本文接下來就該原則做一 簡要回顧, 進而轉到美國在角色權保護上相關測試法之發展, 然後…
故本文接下來就該原則做一 簡要回顧, 進而轉到美國在角色權保護上相關測試法之發展, 然後…
下一代益生菌——卵形拟杆菌研究进展
闫丹丽， 武俊瑞， 史海粟， 洛雪， 岳喜庆， 乌日娜 - 乳业科学与技术, 2020 - dairyst.net.cn
… systematic and comprehensive review of the bacteriological characteristics, functional
characteristics … IBD in 2016: Biologicals and biosimilars in IBD: the road to personalized treatment[J…
characteristics … IBD in 2016: Biologicals and biosimilars in IBD: the road to personalized treatment[J…
[PDF][PDF] 骨化三醇联合常规治疗对慢性肾脏病患者肾功能, 炎性因子及钙磷代谢的影响
徐杨， 李普庆， 姜国芳， 徐彩棉， 夏国宏… - 现代生物医学 …, 2020 - biomed.cnjournals.com
… : a systematic review and meta-analysis [J]. Nephrol Dial Transplant, 2017, 32(1): 111-125
[15] 陈肖蕾, 陶冶, 段思雨, 等. 降低透析液钙浓度对慢性肾脏病- 矿物 质骨代谢异常的影响[J]. …
[15] 陈肖蕾, 陶冶, 段思雨, 等. 降低透析液钙浓度对慢性肾脏病- 矿物 质骨代谢异常的影响[J]. …
[HTML][HTML] 肝细胞癌免疫治疗的现状及发展
焘王， 文涛王 - Journal of Sichuan University (Medical Sciences), 2023 - ncbi.nlm.nih.gov
… As a library, NLM provides access to scientific literature. Inclusion in an NLM database does
not imply … Herein, the status quo and development of HCC immunotherapy are reviewed. …
not imply … Herein, the status quo and development of HCC immunotherapy are reviewed. …
Ⅳ 期原发性肺癌中国治疗指南(2021 年版).
石远凯 - Chinese Journal of Oncology/Zhonghua Zhongliu …, 2021 - search.ebscohost.com
原发性肺癌是中国发病率和死亡率最高的恶性肿瘤, 2015 年中国肺癌新发病例约78.7 万例, 死亡
病例约63.1 万例. 由于侵袭性高, 且缺乏有效的早期发现手段, 导致中国大部分肺癌患者就诊时…
病例约63.1 万例. 由于侵袭性高, 且缺乏有效的早期发现手段, 导致中国大部分肺癌患者就诊时…